Experience improves outcomes and reduces complications with DMEK

Outcomes of Descemet’s membrane endothelial keratoplasty (DMEK) are good in the great majority of patients

Experience improves outcomes and reduces complications with DMEK
Roibeard O’hEineachain
Roibeard O’hEineachain
Published: Saturday, February 10, 2018
Jorge Peraza-Nieves MD Outcomes of Descemet’s membrane endothelial keratoplasty (DMEK) are good in the great majority of patients and get better as a surgeon gains experience with the technique, said Jorge Peraza-Nieves MD, Spain. “After an arbitrary learning curve of about 25 cases, intra- and postoperative complication rates may decrease. Notably, surgeons with a higher annual caseload may pass faster through their learning curve than surgeons performing their first surgeries over an extended period,” Peraza-Nieves told the 22nd ESCRS Winter Meeting. The retrospective, interventional cohort study involved 2,485 eyes undergoing DMEK, performed by 55 surgeons in 23 countries. The indications for surgery were Fuchs’ endothelial corneal dystrophy in 74%, bullous keratopathy in 17%, transplant failure in 8% or other indications in 1%. At six months’ follow-up, BCVA had improved in 90.5% of eyes, remained unchanged in 4.6% and deteriorated in 4.9%. In addition, BCVA was 20/40 or better in 75.4%, 20/25 or better in 45.4% and 20/20 or better in 25.8% for the entire group, with no eyes excluded because of low visual potential. The rates of both intraoperative and postoperative complications were significantly less common for surgeons who had performed more than 100 DMEK procedures than in those who had performed fewer than 100 or fewer than 25 procedures.
Tags: cornea, Belgrade 2018
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...